ValueConnected
Over 5 year WIMENCO is collaborating with ValueConnected. To bring commercialization and Market Access together and implement success.
Hull Associates
Worked together with HULL Associates on projects for the Dutch Med Tech and Pharma Market
Meditech Access
Worked together with MTAC France on projects for the Dutch Med Tech Market
Thinc
Corporation with Thinc Utrecht on HTA modelling
Urgo Medical Project preparation to engage with Sales for Success in The Netherlands
Value Messages on Economic for TELEFLEX in The Netherlands, elaborate with all stakeholders and guide the TELEFLEX sales organization to introduce the Value Messages successful in the market.
J&J Cerenovus Market interviews
Worked together with Centivis on projects
Digipharm’s contact for The Netherlands. Big data collection and digital platforms for payers, HCP and patients to connect outcome to payment.
Olympus: one of the projects together with other consultancy groups.
Worked together with Syneos Health on several projects for Med Tech and Pharma companies
Dexcom
Value Messages for Dexcom in The Netherlands, elaborate with all stakeholders and guide the Dexcom organization to introduce the Value Messages successful in the market.
Market Access Strategy report The Netherlands.
Support with Hospital Access Management in The Netherlands.
Market Access & Strategy support report for The Netherlands.
Stakeholder Mapping Process Strategic Support Global via Kantar Health.
Market Access Strategic Support in Germany with SHI.
Financing Hospitals in Belgium. Sales Support in understanding the changes.
Market Access & Strategic internal leadership preparing for entering 4 Markets (US, FR, Germ and UK) with a new device.
Projectleider vergoedingstitel WGS bij zorgverzekeraar Nederland (ZN en alle zorgverzekeraars).
Voorwaardelijk Toelatingstraject Reumafonds 2018 geaccordeerd.
Desk research Patient support Program The Netherlands via Executive Insight.
Funding options in The Netherlands via Lysiac.
Ondersteuning Farmaceutische onderbouwing Preferentiebeleid In Nederland.
Strategic support on Market Access and Modelling report for the United Kingdom.
Interim Market Access for 8 months. Benelux position.
Prepared a Market Access Strategy for Benelux via ValueConnected.
Market Access Desktop Research The Netherlands via ValueConnected.
Work on Market Access for the Belgium market on HPV testing diagnostics and Company support with contact several stakeholders with individual value messages.
Market Access Support Germany on DuraGraft.
Prepare the stepping stones for entering the German Market with a new Medical Device on AAA/EVAR procedures. Guide the Company through the German healthcare system.
Reimbursement opportunities in The Netherlands for two new diagnostic products for Molecular diagnostics in Oncology. Guidance through the Governmental pathway for renewal of the reimbursement of Molecular Diagnostics by the Dutch Government.
Dutch procedural guidance and field support for a new innovative product on Gastroenterology to be introduced in the Dutch Market.
Worked closely together with LYSIAC on the ILLUMINA project. LYSIAC has been a partner for several years.
Innovative product on ECG diagnostic yet to be introduced in The Netherlands. Preliminary discussions on the roadmap for introduction. Guidance on Value Messages for different stakeholders.
The company is preparing the ground for introduction of an innovative product on Diabetes in The Netherlands. Roadmap and Value Messages where the main topics.
Coding support for a innovative product on Depression in The Netherlands. A non-invasive brain stimulation product.
Interviews with different stakeholders on multiple products and multiple indications in the Dutch Healthcare environment.
Support in the German Market for Ophthalmologists and surgeons on Glaucoma treatment. Field support with direct contact with Health Insurers (SHI) and professional associations (KV’s) together with salesforce in the ambulatory environment.